Quanterix (QTRX) Gross Profit Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.72% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | 4.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.91% |
| Dec 31, 2025 | -9.61% |
| Sep 30, 2025 | -14.62% |
| Jun 30, 2025 | -49.18% |
| Mar 31, 2025 | -20.00% |
| Dec 31, 2024 | 14.24% |
| Sep 30, 2024 | 3.83% |
| Jun 30, 2024 | 14.51% |
| Mar 31, 2024 | 15.98% |
| Dec 31, 2023 | 53.48% |
| Sep 30, 2023 | 88.35% |
| Jun 30, 2023 | 133.45% |
| Mar 31, 2023 | 13.45% |
| Dec 31, 2022 | -34.50% |
| Sep 30, 2022 | -32.40% |
| Jun 30, 2022 | -40.05% |
| Mar 31, 2022 | -13.77% |
| Dec 31, 2021 | 28.27% |
| Sep 30, 2021 | -27.77% |
| Jun 30, 2021 | 166.14% |
| Mar 31, 2021 | 139.97% |
| Dec 31, 2020 | 119.23% |
| Sep 30, 2020 | 200.10% |
| Jun 30, 2020 | -24.79% |
| Mar 31, 2020 | 13.42% |
| Dec 31, 2019 | 31.82% |
| Sep 30, 2019 | 25.70% |
| Jun 30, 2019 | 74.45% |
| Mar 31, 2019 | 89.38% |
| Dec 31, 2018 | 80.77% |
| Sep 30, 2018 | 118.13% |
| Jun 30, 2018 | 17.58% |
| Mar 31, 2018 | -24.37% |